Refine by MP, party, committee, province, or result type.

Results 16-20 of 20
Sorted by relevance | Sort by date: newest first / oldest first

Industry committee  To start, I think the funding agencies can provide support mainly at the discovery stage, and also at the proof of principle stage. Beyond that, it would take much more investment and resources to be able to go--

April 17th, 2008Committee meeting

Dr. Pierre Chartrand

Industry committee  We can look at it in two ways. In terms of the applications we receive, the ones that are funded represent about 20% to 25%, depending on the competition. But the ones that pass what we call the funding level--that is, they are fundable applications--represent about one third.

April 17th, 2008Committee meeting

Dr. Pierre Chartrand

Industry committee  Okay. We are fully endorsing the setting of priorities in health research in order to be accountable to Canadians. In conclusion, translation of health research into health, social, and economic benefits in collaboration with academic, public, and private sector partners is critical to solving many of the health-related issues that are important to Canadians.

April 17th, 2008Committee meeting

Dr. Pierre Chartrand

Industry committee  Honourable members of Parliament, I am very grateful to you for the opportunity to appear before you today to talk about Canada's science and technology policy in the context of health research. I appreciate the opportunity to present to the members of this committee on how CIHR contributes to the government's vision for Canada to become a world leader in science and technology.

April 17th, 2008Committee meeting

Dr. Pierre Chartrand

Industry committee  Sure. Composed of 13 virtual institutes headed by leading Canadian researchers in their respective disciplines, CIHR provides leadership and support to more than 11,000 health researchers and trainees across Canada. CIHR was designed to address research challenges across the spectrum of health research.

April 17th, 2008Committee meeting

Dr. Pierre Chartrand